![Tauriga Sciences, Inc.](/news-release/logo/254204/0/254204.jpg?lastModified=12%2F09%2F2016%2023%3A09%3A31&size=2)
Tauriga Sciences Inc. Completes Acquisition of Innovative Synthetic Biology Firm Pilus Energy LLC and Positions Itself in Nascent $10 Billion Annual Wastewater-to-Value Market
28 janv. 2014 09h01 HE
|
Tauriga Sciences Inc
CINCINNATI, Jan. 28, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
![Tauriga Sciences, Inc.](/news-release/logo/254204/0/254204.jpg?lastModified=12%2F09%2F2016%2023%3A09%3A31&size=2)
Tauriga Sciences Inc. Appoints Mr. Jason E. Barkeloo as Member of the Company's Business Advisory Board
27 janv. 2014 07h59 HE
|
Tauriga Sciences Inc
CINCINNATI, Jan. 27, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
![Tauriga Sciences, Inc.](/news-release/logo/254204/0/254204.jpg?lastModified=12%2F09%2F2016%2023%3A09%3A31&size=2)
Tauriga Sciences Inc. Highlights Pilus Energy's Genetic Rights Management ("GeRM") Keys for the Protection of Its Synthetic Biology Based BactoBots(TM)
24 janv. 2014 09h10 HE
|
Tauriga Sciences Inc
NEW YORK, Jan. 24, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
![Tauriga Sciences, Inc.](/news-release/logo/254204/0/254204.jpg?lastModified=12%2F09%2F2016%2023%3A09%3A31&size=2)
Tauriga Sciences Inc. Repays and Retires Convertible Note Held by Asher Enterprises, Inc. for Principal Amount of $37,500 USD and Issues Important Clarification to Shareholders
21 janv. 2014 17h59 HE
|
Tauriga Sciences Inc
NEW YORK, Jan. 21, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
![Tauriga Sciences, Inc.](/news-release/logo/254204/0/254204.jpg?lastModified=12%2F09%2F2016%2023%3A09%3A31&size=2)
Tauriga Sciences Inc. Receives Product Engineering Plan for Polychlorinated Biphenyl Remediating BactoBots(TM) for the Nuclear Industry ("NuclearBot(TM)")
21 janv. 2014 09h02 HE
|
Tauriga Sciences Inc
NEW YORK, Jan. 21, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
![Tauriga Sciences, Inc.](/news-release/logo/254204/0/254204.jpg?lastModified=12%2F09%2F2016%2023%3A09%3A31&size=2)
Tauriga Sciences, Inc. Elects to Purchase Key Man Insurance Policies for Both Its Chief Executive Officer and Chief Operating Officer for $6,000,000 USD and $3,000,000 USD Respectively
17 janv. 2014 08h15 HE
|
Tauriga Sciences Inc
DANBURY, Conn., Jan. 17, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
![Tauriga Sciences, Inc.](/news-release/logo/254204/0/254204.jpg?lastModified=12%2F09%2F2016%2023%3A09%3A31&size=2)
Tauriga Sciences Inc. Presents Detailed Illustration of Pilus Energy's GalvaniBot(TM) Powered Electrogenic Bioreactor Waste-to-Value Technology Platform
16 janv. 2014 07h50 HE
|
Tauriga Sciences Inc
SAN FRANCISCO, Jan. 16, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
![Tauriga Sciences, Inc.](/news-release/logo/254204/0/254204.jpg?lastModified=12%2F09%2F2016%2023%3A09%3A31&size=2)
Tauriga Sciences Inc. Focused on Securing Several Potential Sources of Non-Dilutive Funding
08 janv. 2014 07h45 HE
|
Tauriga Sciences Inc
NEW YORK, Jan. 8, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
![Tauriga Sciences, Inc.](/news-release/logo/254204/0/254204.jpg?lastModified=12%2F09%2F2016%2023%3A09%3A31&size=2)
Tauriga Sciences Inc. Invited to Present at 24th Annual Institutional Investor Conference on March 03, 2014 at The University Club in New York City
03 janv. 2014 09h00 HE
|
Tauriga Sciences Inc
NEW YORK, Jan. 3, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...
![Tauriga Sciences, Inc.](/news-release/logo/254204/0/254204.jpg?lastModified=12%2F09%2F2016%2023%3A09%3A31&size=2)
Tauriga Sciences Inc. Receives Positive Update From Immunovative Therapies Ltd. and Expected Start Date for Pivotal Phase II/III Breast Cancer Trial
03 janv. 2014 08h10 HE
|
Tauriga Sciences Inc
NEW YORK, Jan. 3, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license...